[1]
|
Vallon, V. and Thomson, S.C. (2020) The Tubular Hypothesis of Nephron Filtration and Diabetic Kidney Disease. Na-ture Reviews Nephrology, 16, 317-336. https://doi.org/10.1038/s41581-020-0256-y
|
[2]
|
Kato, M. and Natarajan, R. (2019) Epigenetics and Epigenomics in Diabetic Kidney Disease and Metabolic Memory. Nature Reviews Nephrology, 15, 327-345. https://doi.org/10.1038/s41581-019-0135-6
|
[3]
|
Anders, H.J., Huber, T.B., Isermann, B., et al. (2018) CKD in Diabetes: Diabetic Kidney Disease versus Nondiabetic Kidney Disease. Nature Reviews Nephrology, 14, 361-377. https://doi.org/10.1038/s41581-018-0001-y
|
[4]
|
Azushima, K., Gurley, S.B. and Coffman, T.M. (2018) Modelling Diabetic Nephropathy in Mice. Nature Reviews Nephrology, 14, 48-56. https://doi.org/10.1038/nrneph.2017.142
|
[5]
|
Molitch, M.E., Adler, A.I., Flyvbjerg, A., et al. (2015) Diabetic Kid-ney Disease: A Clinical Update from Kidney Disease: Improving Global Outcomes. Kidney International, 87, 20-30. https://doi.org/10.1038/ki.2014.128
|
[6]
|
Majchrzak, C., Cougnard-Gregoire, A., Le-Goff, M., et al. (2022) Skin Autofluorescence of Advanced Glycation End-Products and Mortality in Older Adults: The Roles of Chronic Kidney Disease and Diabetes. Nutrition, Metabolism and Cardiovascular Diseases, 32, 2526-2533. https://doi.org/10.1016/j.numecd.2022.08.009
|
[7]
|
Wu, X.Q., Zhang, D.D., Wang, Y.N., et al. (2021) AGE/RAGE in Diabetic Kidney Disease and Ageing Kidney. Free Radical Biology and Medicine, 171, 260-271. https://doi.org/10.1016/j.freeradbiomed.2021.05.025
|
[8]
|
Byun, K., Yoo, Y., Son, M., et al. (2017) Advanced Glycation End-Products Produced Systemically and by Macrophages: A Common Contributor to Inflammation and De-generative Diseases. Pharmacology & Therapeutics, 177, 44-55. https://doi.org/10.1016/j.pharmthera.2017.02.030
|
[9]
|
Yacoub, R., Nugent, M., Cai, W., et al. (2017) Advanced Glycation end Products Dietary Restriction Effects on Bacterial Gutmicrobiota in Peritoneal Dialysis Patients; a Random-ized Open Label Controlled Trial. PLOS ONE, 12, e184789. https://doi.org/10.1371/journal.pone.0184789
|
[10]
|
Rungratanawanich, W., Qu, Y., Wang, X., et al. (2021) Ad-vanced Glycation End Products (AGEs) and Other Adducts in Aging-Related Diseases and Alcohol-Mediated Tissue Injury. Experimental & Molecular Medicine, 53, 168-188.
https://doi.org/10.1038/s12276-021-00561-7
|
[11]
|
Yamagishi, S. and Matsui, T. (2010) Advanced Glycation End Products, Oxidative Stress and Diabetic Nephropathy. Oxidative Medicine and Cellular Longevity, 3, 101-108. https://doi.org/10.4161/oxim.3.2.11148
|
[12]
|
Shu, M., Cheng, W., Jia, X., et al. (2023) AGEs Promote Atheroscle-rosis by Increasing LDL Transcytosis across Endothelial Cells via RAGE/NF-kappaB/Caveolin-1 Pathway. Molecular Medicine, 29, Article No. 113.
https://doi.org/10.1186/s10020-023-00715-5
|
[13]
|
Chaudhuri, J., Bains, Y., Guha, S., et al. (2018) The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality. Cell Metabo-lism, 28, 337-352.
https://doi.org/10.1016/j.cmet.2018.08.014
|
[14]
|
Fotheringham, A.K., Gallo, L.A., Borg, D.J., et al. (2022) Ad-vanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney? Nutri-ents, 14, Article No. 2675.
https://doi.org/10.3390/nu14132675
|
[15]
|
Steenbeke, M., Speeckaert, R., Desmedt, S., et al. (2022) The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases. International Journal of Molecular Sci-ences, 23, Article No. 3439.
https://doi.org/10.3390/ijms23073439
|
[16]
|
Kumar, P.A., Chitra, P.S. and Reddy, G.B. (2016) Advanced Glycation End Products Mediated Cellular and Molecular Events in the Pathology of Diabetic Nephropathy. BioMolecular Con-cepts, 7, 293-309.
https://doi.org/10.1515/bmc-2016-0021
|
[17]
|
叶成松, 王贻坤, 叶山东. 晚期糖基化终末产物的特性及其检测[J]. 国际病理科学与临床杂志, 2013, 33(2): 175-178.
|
[18]
|
Thurlow, J.S., Joshi, M., Yan, G., et al. (2021) Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. American Journal of Nephrology, 52, 98-107. https://doi.org/10.1159/000514550
|
[19]
|
Poojary, M.M. and Lund, M.N. (2022) Chemical Stability of Proteins in Foods: Oxidation and the Maillard Reaction. Annual Review of Food Science and Technology, 13, 35-58. https://doi.org/10.1146/annurev-food-052720-104513
|
[20]
|
Poulsen, M.W., Hedegaard, R.V. andersen, J.M., et al. (2013) Advanced Glycation End Products in Food and Their Effects on Health. Food and Chemical Toxicol-ogy, 60, 10-37. https://doi.org/10.1016/j.fct.2013.06.052
|
[21]
|
Liang, Z., Chen, X., Yang, Z., et al. (2022) Sodium Ions Affect Pyrraline Formation in the Maillard Reaction with Lys-Containing Dipeptides and Tripeptides. Frontiers in Nutrition, 9, Article ID: 874650.
https://doi.org/10.3389/fnut.2022.874650
|
[22]
|
Liu, R., Zhang, M., Xu, L., et al. (2022) Fluorescent Advanced Glycation End Products in Type 2 Diabetes and Its Association with Diabetes Duration, Hemoglobin A1c, and Diabetic Complications. Frontiers in Nutrition, 9, Article ID: 1083872. https://doi.org/10.3389/fnut.2022.1083872
|
[23]
|
Nakano, T., Mizumasa, T., Kuroki, Y., et al. (2020) Advanced Glycation End Products Are Associated with Immature Angiogenesis and Peritoneal Dysfunction in Patients on Perito-neal Dialysis. Peritoneal Dialysis International, 40, 67-75. https://doi.org/10.1177/0896860819878344
|
[24]
|
Jiang, J., Chen, P., Chen, J., et al. (2012) Accumulation of Tissue Advanced Glycation End Products Correlated with Glucose Exposure Dose and Associated with Cardiovascular Morbidity in Patients on Peritoneal Dialysis. Atherosclerosis, 224, 187-194. https://doi.org/10.1016/j.atherosclerosis.2012.06.022
|
[25]
|
Meerwaldt, R., Hartog, J.W., Graaff, R., et al. (2005) Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Pre-dicts Mortality in Hemodialysis Patients. Journal of the American Society of Nephrology, 16, 3687-3693. https://doi.org/10.1681/ASN.2005020144
|
[26]
|
Arsov, S., Graaff, R., Morariu, A.M., et al. (2010) Does Hepatitis C Increase the Accumulation of Advanced Glycation End Products in Haemodialysis Patients? Nephrology Dialysis Transplantation, 25, 885-891.
https://doi.org/10.1093/ndt/gfp564
|
[27]
|
Koyama, H. and Nishizawa, Y. (2010) AGEs/RAGE in CKD: Irreversible Metabolic Memory Road toward CVD? European Journal of Clinical Investigation, 40, 623-635. https://doi.org/10.1111/j.1365-2362.2010.02298.x
|
[28]
|
Thornalley, P.J. (2006) Advanced Glycation End Products in Renal Failure. Journal of Renal Nutrition, 16, 178-184.
https://doi.org/10.1053/j.jrn.2006.04.012
|
[29]
|
Dozio, E., Caldiroli, L., Molinari, P., et al. (2023) Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease. Antioxidants (Basel), 12, Article No. 584.
https://doi.org/10.3390/antiox12030584
|
[30]
|
Gnudi, L., Coward, R. and Long, D.A. (2016) Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms. Trends in Endocrinology and Metabolism, 27, 820-830. https://doi.org/10.1016/j.tem.2016.07.002
|
[31]
|
Reidy, K., Kang, H.M., Hostetter, T., et al. (2014) Molecular Mechanisms of Diabetic Kidney Disease. Journal of Clinical Investigation, 124, 2333-2340. https://doi.org/10.1172/JCI72271
|
[32]
|
Bansode, S., Bashtanova, U., Li, R., et al. (2020) Glycation Changes Mo-lecular Organization and Charge Distribution in Type I Collagen Fibrils. Scientific Reports, 10, Article No. 3397. https://doi.org/10.1038/s41598-020-60250-9
|
[33]
|
Hadley, J.C., Meek, K.M. and Malik, N.S. (1998) Glycation Changes the Charge Distribution of Type I Collagen Fibrils. Glycoconjugate Journal, 15, 835-840. https://doi.org/10.1023/A:1006928403140
|
[34]
|
Cepas, V., Collino, M., Mayo, J.C., et al. (2020) Redox Signaling and Advanced Glycation End Products (AGEs) in Diet-Related Diseases. Antioxidants (Basel), 9, Article No. 142. https://doi.org/10.3390/antiox9020142
|
[35]
|
Gill, P.S. and Wilcox, C.S. (2006) NADPH Oxidases in the Kidney. Antioxidants & Redox Signaling, 8, 1597-1607.
https://doi.org/10.1089/ars.2006.8.1597
|
[36]
|
Dozio, E., Vettoretti, S., Lungarella, G., et al. (2021) Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress. Biomedicines, 9, Article No. 405.
https://doi.org/10.3390/biomedicines9040405
|
[37]
|
Xie, J., Mendez, J.D., Mendez-Valenzuela, V., et al. (2013) Cellular Signalling of the Receptor for Advanced Glycation End Products (RAGE). Cell Signaling, 25, 2185-2197. https://doi.org/10.1016/j.cellsig.2013.06.013
|
[38]
|
Goldin, A., Beckman, J.A., Schmidt, A.M., et al. (2006) Ad-vanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury. Circulation, 114, 597-605. https://doi.org/10.1161/CIRCULATIONAHA.106.621854
|
[39]
|
Liebisch, M., Bondeva, T., Franke, S., et al. (2014) Activation of the Receptor for Advanced Glycation End Products Induces Nuclear Inhibitor of Protein Phospha-tase-1 Suppression. Kidney International, 86, 103-117.
https://doi.org/10.1038/ki.2014.3
|
[40]
|
Matoba, K., Takeda, Y., Nagai, Y., et al. (2020) Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease. Biomedicines, 8, Article No. 40. https://doi.org/10.3390/biomedicines8020040
|
[41]
|
Duni, A., Liakopoulos, V., Roumeliotis, S., et al. (2019) Oxida-tive Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne’s Thread. International Journal of Molecular Sciences, 20, Article No. 3711.
https://doi.org/10.3390/ijms20153711
|
[42]
|
Chao, P.C., Huang, C.N., Hsu, C.C., et al. (2010) Association of Die-tary AGEs with Circulating AGEs, Glycated LDL, IL-1alpha and MCP-1 Levels in Type 2 Diabetic Patients. European Journal of Nutrition, 49, 429-434.
https://doi.org/10.1007/s00394-010-0101-3
|
[43]
|
Uribarri, J. and He, J.C. (2015) The Low AGE Diet: A Neglected Aspect of Clinical Nephrology Practice? Nephron, 130, 48-53. https://doi.org/10.1159/000381315
|
[44]
|
Jung, E., Kang, W.S., Jo, K., et al. (2019) Ethyl Pyruvate Prevents Renal Damage Induced by Methylglyoxal-Derived Advanced Glycation End Products. Journal of Diabetes Research, 2019, Article ID: 4058280.
https://doi.org/10.1155/2019/4058280
|
[45]
|
Lin, J., Gwyneth, T.Y., Leong, L.P., et al. (2018) Steamed Bread En-riched with Quercetin as an Antiglycative Food Product: Its Quality Attributes and Antioxidant Properties. Food & Func-tion, 9, 3398-3407.
https://doi.org/10.1039/C8FO00818C
|
[46]
|
Yin, M.C. (2015) Inhibitory Effects and Actions of Pentacyclic Triter-penes upon Glycation. Biomedicine (Taipei), 5, Article No. 13. https://doi.org/10.7603/s40681-015-0013-x
|
[47]
|
Jensen, L.J., Denner, L., Schrijvers, B.F., et al. (2006) Renal Ef-fects of a Neutralising RAGE-Antibody in Long-Term Streptozotocin-Diabetic Mice. Journal of Endocrinology, 188, 493-501. https://doi.org/10.1677/joe.1.06524
|
[48]
|
Thornalley, P.J. (2003) Use of Aminoguanidine (Pimagedine) to Prevent the Formation of Advanced Glycation End Products. Archives of Biochemistry and Biophysics, 419, 31-40. https://doi.org/10.1016/j.abb.2003.08.013
|
[49]
|
Degenhardt, T.P., Alderson, N.L., Arrington, D.D., et al. (2002) Pyridoxamine Inhibits Early Renal Disease and Dyslipidemia in the Streptozotocin-Diabetic Rat. Kidney International, 61, 939-950.
https://doi.org/10.1046/j.1523-1755.2002.00207.x
|
[50]
|
Yang, P.Y., Li, P.C. and Feng, B. (2019) Protective Effects of Gliclazide on High Glucose and AGEs-Induced Damage of Glomerular Mesangial Cells and Renal Tubular Epithelial Cells via Inhibiting RAGE-p22phox-NF-κB Pathway. European Review for Medical and Pharmacological Sciences, 23, 9099-9107.
|
[51]
|
Muthenna, P., Raghu, G., Kumar, P.A., et al. (2014) Effect of Cinnamon and Its Procyanidin-B2 En-riched Fraction on Diabetic Nephropathy in Rats. Chemico-Biological Interactions, 222, 68-76. https://doi.org/10.1016/j.cbi.2014.08.013
|
[52]
|
Rabbani, N. and Thornalley, P.J. (2019) Glyoxalase 1 Modulation in Obesity and Diabetes. Antioxidants & Redox Signaling, 30, 354-374. https://doi.org/10.1089/ars.2017.7424
|
[53]
|
Wang, Z.H., Hsu, C.C., Huang, C.N., et al. (2010) Anti-Glycative Ef-fects of Oleanolic Acid and Ursolic Acid in Kidney of Diabetic Mice. European Journal of Pharmacology, 628, 255-260. https://doi.org/10.1016/j.ejphar.2009.11.019
|
[54]
|
Kaida, Y., Fukami, K., Matsui, T., et al. (2013) DNA Aptamer Raised against AGEs Blocks the Progression of Experimental Diabetic Nephropathy. Diabetes, 62, 3241-3250. https://doi.org/10.2337/db12-1608
|
[55]
|
Bucciarelli, L.G., Wendt, T., Rong, L., et al. (2002) RAGE Is a Mul-ti-Ligand Receptor of the Immunoglobulin Super-Family: Implications for Homeostasis and Chronic Disease. Cellular and Molecular Life Sciences, 59, 1117-1128.
https://doi.org/10.1007/s00018-002-8491-x
|
[56]
|
Kawanishi, K., Honda, K., Tsukada, M., et al. (2013) Neutral So-lution Low in Glucose Degradation Products Is Associated with Less Peritoneal Fibrosis and Vascular Sclerosis in Pa-tients Receiving Peritoneal Dialysis. Peritoneal Dialysis International, 33, 242-251. https://doi.org/10.3747/pdi.2011.00270
|
[57]
|
Van Tellingen, A., Schalkwijk, C.G., Teerlink, T., et al. (2005) Influ-ence of Different Haemodialysis Modalities on AGE Peptide Levels: Intradialytic versus Long-Term Results. Nephron Clinical Practice, 100, c1-c7.
https://doi.org/10.1159/000084106
|
[58]
|
Floridi, A., Antolini, F., Galli, F., et al. (2002) Daily Haemodialysis Im-proves Indices of Protein Glycation. Nephrology Dialysis Transplantation, 17, 871-878. https://doi.org/10.1093/ndt/17.5.871
|